Greg Rak

Greg Rak is the Senior Director and Head of Safety Assessment at Kallyope. Greg has over 25 years of experience in preclinical and clinical drug development. Prior to joining Kallyope, Greg was a Research Investigator II and Senior Research Investigator II/Principal Scientist in Drug Safety Evaluation at Bristol Myers Squibb. In these roles, they were responsible for leading and directing preclinical safety evaluations across multiple therapeutic areas, including immuno-oncology. Greg has also served as a Senior Principal Scientist at Bristol Myers Squibb.

Dr. Greg Rak attended the University of Pennsylvania, where they obtained their V.M.D./Ph.D. in Cell and Molecular Biology / Immunology. Greg also holds a Bachelor of Science (B.S.) from the University of Delaware in Animal Science, as well as a Bachelor of Arts (B.A.) from Haverford College in Philosophy.

They work with Shirly Pinto - CSO, Anita Kawatra - EVP, Corporate Affairs, and Patrick Flanigan - CFO. Greg Rak reports to Jay Galeota, CEO & President.